TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare

Rhea-AI Summary

TelyRx (TSX: TELY, OTCQX: TELYF) announced a major expansion of its Clearwater, Florida headquarters and pharmacy operations after surpassing one million prescriptions filled and reporting first-quarter revenue growth of 180% year-over-year. The move more than triples the company’s physical footprint to support rising demand for its digital healthcare and online pharmacy platform.

TelyRx’s integrated platform links patients with licensed providers and pharmacy services for FDA-approved medications used in routine care. The company is also recruiting across pharmacy, clinical and fulfillment roles to preserve service levels and support scaling as adoption of virtual care solutions increases.

Positive

• Q1 revenue growth 180% YoY, signaling rapid topline expansion
• Headquarters and pharmacy footprint more than tripled to meet demand
• One million prescriptions filled milestone demonstrates strong platform utilization
• New hiring across pharmacy, clinical and fulfillment roles supports future volume

Negative

• None.

News Market Reaction – TELYF

+15.00%

+15.00% News Effect

On the day this news was published, TELYF gained 15.00%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Expansion follows milestone of one million prescriptions filled

CLEARWATER, Fla., July 14, 2026 /PRNewswire/ -- TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a digital healthcare and online pharmacy platform, today announced a major expansion of its Clearwater headquarters and pharmacy operations, following the milestone of one million prescriptions filled and first-quarter revenue growth of 180% year-over-year. The move more than triples TelyRx's overall footprint to meet growing consumer demand for fast, convenient prescription care.

TelyRx's integrated digital platform connects patients with licensed healthcare providers and pharmacy services through a seamless online experience, simplifying access to FDA-approved medications for routine care needs.

TelyRx is also seeking to hire across its pharmacy, clinical and fulfillment roles in order to maintain its high service levels, rapid turnaround times and order accuracy.

"Filling one million prescriptions is a milestone worth celebrating, but what matters most is how many customers come back for a second, third or tenth order," said Vanessa Slowey, President and Chief Executive Officer of TelyRx. "Their repeat orders tell us that fast, affordable access to everyday medications is exactly what they've been waiting for. This added capacity helps us keep that promise as more people find us."

The larger Clearwater presence will enable TelyRx to scale operations in response to increasing consumer adoption of virtual care solutions.

About TelyRx
TelyRx is a technology-enabled healthcare and pharmacy services company operating a digital pharmacy platform that connects patients with independent, state-licensed providers to access more than 450 everyday medications across 48 U.S. states and territories. The company fulfills prescriptions through its licensed retail pharmacies and offers fast, convenient delivery directly to patients' doors.

For more information, visit www.telyrx.com

Forward-Looking Statements
This press release includes certain statements that may be deemed "forward‐looking statements" including, but not limited to, statements regarding the Company's proposed scaling of facilities and operations, growing customer demand and the expansion of its workforce to maintain high service levels, turnaround times and order accuracy and delivery of a seamless, reliable customer experience. Forward‐looking statements involve known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward‐looking statements. Such factors include, but are not limited to, construction plans, regulatory approvals, availability of qualified personnel, and the factors discussed in the section entitled "Risk Factors" in the management discussion and analysis of the Company dated May 12, 2026, and filed on SEDAR+. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward‐looking statements, there may be other factors that cause actions, events, or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date hereof and, other than as required by law, the Company disclaims any obligation to update any forward‐looking statements, whether because of new information, future events, or results or otherwise. There can be no assurance that forward‐looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward‐looking statements are based on several assumptions, which may prove to be incorrect, including but not limited to the assumptions discussed in this section. Accordingly, readers should not place undue reliance on forward‐looking statements.

Neil Weber
Investor Relations
(647) 222-0574
investors@telyrx.com

Media Contact: Havas Red
TelyRxPress@havasred.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/telyrx-expands-operations-in-clearwater-fla-tripling-footprint-to-meet-growing-demand-for-digital-healthcare-302824442.html

SOURCE TelyRx Holdings Inc.

FAQ

What expansion did TelyRx (TELYF) announce for its Clearwater, Florida operations on July 14, 2026?

TelyRx announced it is more than tripling its Clearwater headquarters and pharmacy footprint. According to TelyRx, this larger presence is designed to handle growing consumer demand and scale its digital healthcare and online pharmacy operations as virtual care adoption increases.

How fast is TelyRx (TELYF) revenue growing according to its latest update?

TelyRx reported first-quarter revenue growth of 180% year-over-year. According to TelyRx, this strong revenue increase accompanies rising demand for its digital healthcare and online pharmacy services and supports the decision to significantly expand its Clearwater operational footprint.

What milestone in prescriptions has TelyRx (TELYF) reached with its digital pharmacy platform?

TelyRx has surpassed one million prescriptions filled on its platform. According to TelyRx, this utilization milestone reflects repeat customer demand for fast, convenient access to FDA-approved medications for routine care, reinforcing the need to expand capacity in Clearwater.

How will the TelyRx (TELYF) Clearwater expansion affect its hiring plans?

The expansion is prompting TelyRx to seek additional staff across pharmacy, clinical and fulfillment roles. According to TelyRx, these hires are intended to maintain high service levels, rapid turnaround times and order accuracy as prescription volumes and virtual care adoption increase.

What services does the TelyRx (TELYF) digital healthcare platform provide after its Clearwater expansion?

TelyRx’s platform connects patients with licensed healthcare providers and integrated pharmacy services. According to TelyRx, it simplifies online access to FDA-approved medications for routine care needs, and the expanded Clearwater facility is intended to support this growing digital healthcare demand.